Christophe Nicot, PhD, Kansas University Medical Center, United States of America
Molecular Cancer is calling for submissions to our Collection on 'Advances in Nanomedicine for Cancer Therapy.' This Collection aims to explore innovative research and breakthrough developments in the application of nanotechnology for cancer diagnosis, treatment, and management.
Molecular Cancer is calling for submissions to our Collection on 'Advances in Nanomedicine for Cancer Therapy'. This Collection aims to explore innovative research and breakthrough developments in the application of nanotechnology for cancer diagnosis, treatment, and management.
Topics of interest include, but are not limited to, nanoparticle-based drug delivery systems, targeted therapy, nanomaterials for imaging and early detection, immunotherapy, and personalized medicine approaches. We seek contributions that highlight novel methodologies, clinical trials, and interdisciplinary research that push the boundaries of current cancer therapies.
Image credit: © Chaudary / Generated with AI / Stock.adobe.com
There are currently no articles in this collection.
This Collection welcomes submission of Research Articles and Reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Advances in Nanomedicine for Cancer Therapy" under the “Details” tab during the submission stage. Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editor has no competing interests with the submissions which are handled through the peer-review process. The peer-review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.